4//SEC Filing
Reents Scott T 4
Accession 0001415889-23-003854
CIK 0001551152other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 5:04 PM ET
Size
8.6 KB
Accession
0001415889-23-003854
Insider Transaction Report
Form 4
AbbVie Inc.ABBV
Reents Scott T
EVP, CHIEF FINANCIAL OFFICER
Transactions
- Sale
Common Stock, $0.01 par value
2023-03-01$153.38/sh−850$130,373→ 809 total - Sale
Common Stock, $0.01 par value
2023-03-01$153.06/sh−15,092$2,309,982→ 1,659 total - Tax Payment
Common Stock, $0.01 par value
2023-02-28$154.28/sh−12,683$1,956,733→ 16,751 total
Footnotes (2)
- [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.37 to $153.36, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.37 to $153.47, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
AbbVie Inc.
CIK 0001551152
Entity typeother
Related Parties
1- filerCIK 0001937048
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 5:04 PM ET
- Size
- 8.6 KB